Alpha Tau Medical Ltd. Ordinary Shares DRTS · Stock Open Alpha Tau Medical Ltd. Ordinary Shares in new tab
Alpha Tau Medical Ltd. Ordinary Shares Analysis (DRTS)
Is Alpha Tau Medical Ltd. Ordinary Shares a good investment? Alpha Tau Medical Ltd. Ordinary Shares (DRTS) is currently trading at 14.51 USD. Market analysts have a consensus price target of 17.80 USD. This suggests a potential upside from current levels.
Earnings Schedule: Alpha Tau Medical Ltd. Ordinary Shares is expected to release its next earnings report on Nov. 19, 2026. The market consensus estimate for Forward EPS is -0.53.
Investor FAQ
Does Alpha Tau Medical Ltd. Ordinary Shares pay a dividend?
No, it does not currently pay a dividend.
What asset class is Alpha Tau Medical Ltd. Ordinary Shares?
Alpha Tau Medical Ltd. Ordinary Shares is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 19, 2026. The company currently has a trailing EPS of -1.04.
Company Profile
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.
Community Discussion